Although these studies suggest that PPARγ functions as a tumor suppressor factorand its activation might be beneficialfor patients with tumors, PPARγ agonists have been shown also toincrease the frequency of colon tumors [29] and to promote edema[30]. This evidence concerns the gene PPARG and colonic neoplasm.